LAURA MCNEIL: Open Payments
NPI 1962897769 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 74 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,020 · 2025 $1,238
Food & beverage: $1,238
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $238 |
| ABBVIE INC. | 13 | $194 |
| AstraZeneca Pharmaceuticals LP | 7 | $185 |
| Lilly USA, LLC | 7 | $115 |
| Astellas Pharma US Inc | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $62 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Amgen Inc. | 3 | $47 |
| Corcept Therapeutics | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: FARXIGA, JARDIANCE, Veozah, Wegovy, REXULTI, LINZESS, Rybelsus, BREZTRI.
Industry payments across OH — which companies pay providers there.
